New NIH consortium award to enhance clinical trials for Alzheimer’s disease, related dementias
Effort streamlines study infrastructure to improve recruitment diversity, advance research.
A new clinical trials consortium funded by the National Institutes of Health is expected to accelerate and expand studies for therapies in Alzheimer’s disease and related dementias. The infrastructure of 35 sites across the United States — called the Alzheimer’s Clinical Trial Consortium (ACTC) — will address the timeframe, complexity and expense of the recruitment process and site activation for Alzheimer’s trials to find new and effective ways to treat or prevent these devastating disorders.
- 311 reads
Human Rights
Conscience, Hope, and Action: Keys to Global Peace and Sustainability
Ringing FOWPAL’s Peace Bell for the World:Nobel Peace Prize Laureates’ Visions and Actions
Protecting the World’s Cultural Diversity for a Sustainable Future
The Peace Bell Resonates at the 27th Eurasian Economic Summit
Puppet Show I International Friendship Day 2020